Published in Drug Week, January 7th, 2005
The CRADA program, authorized under the Federal Technology Transfer Act of 1986, allows federal laboratories and businesses to form commercial partnerships that help move new technologies into the marketplace. PhytoMedical, through its wholly owned subsidiary, Polyphenol Technologies Corporation, has entered into the CRADA to, among other objectives, synthesize the active components found in cinnamon and characterize their beneficial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.